Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A gain‐of‐glycosylation mutation associated with myoclonus‐dystonia syndrome affects trafficking and processing of mouse ε‐sarcoglycan in the late secretory pathway

Identifieur interne : 001237 ( Istex/Curation ); précédent : 001236; suivant : 001238

A gain‐of‐glycosylation mutation associated with myoclonus‐dystonia syndrome affects trafficking and processing of mouse ε‐sarcoglycan in the late secretory pathway

Auteurs : Adrian Waite [Royaume-Uni] ; Maria Cristina De Rosa [Italie] ; Andrea Brancaccio [Italie] ; Derek J. Blake [Royaume-Uni]

Source :

RBID : ISTEX:C7EE1610CBF1DC4111B52196C746F0085EC33EEC

English descriptors

Abstract

Missense mutations in the SGCE gene encoding ε‐sarcoglycan account for approximately 15% of SGCE‐positive cases of myoclonus‐dystonia syndrome (MDS) in humans. In this study, we show that while the majority of MDS‐associated missense mutants modeled with a murine ε‐sarcoglycan cDNA are substrates for endoplasmic reticulum‐associated degradation, one mutant, M68T (analogous to human c.275T>C, p.M92T), located in the Ig‐like domain of ε‐sarcoglycan, results in a gain‐of‐glycosylation mutation producing a protein that is targeted to the plasma membrane, albeit at reduced levels compared to wild‐type ε‐sarcoglycan. Removal of the ectopic N‐linked glycan failed to restore efficient plasma membrane targeting of M68T demonstrating that the substitution rather than the glycan was responsible for the trafficking defect of this mutant. M68T also colocalized with CD63‐positive vesicles in the endosomal–lysosomal system and was found to be more susceptible to lysosomal proteolysis than wild‐type ε‐sarcoglycan. Finally, we demonstrate impaired ectodomain shedding of M68T, a process that occurs physiologically for ε‐sarcoglycan resulting in the lysosomal trafficking of the intracellular C‐terminal domain of the protein. Our findings show that functional analysis of rare missense mutations can provide a mechanistic insight into the pathogenesis of MDS and the physiological role of ε‐sarcoglycan. Hum Mutat 32:1246–1258, 2011. ©2011 Wiley Periodicals, Inc.

Url:
DOI: 10.1002/humu.21561

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:C7EE1610CBF1DC4111B52196C746F0085EC33EEC

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A gain‐of‐glycosylation mutation associated with myoclonus‐dystonia syndrome affects trafficking and processing of mouse ε‐sarcoglycan in the late secretory pathway</title>
<author>
<name sortKey="Waite, Adrian" sort="Waite, Adrian" uniqKey="Waite A" first="Adrian" last="Waite">Adrian Waite</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Heath Park, Cardiff, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Heath Park, Cardiff</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Pharmacology, University of Oxford, Oxford, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacology, University of Oxford, Oxford</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="De Rosa, Maria Cristina" sort="De Rosa, Maria Cristina" uniqKey="De Rosa M" first="Maria Cristina" last="De Rosa">Maria Cristina De Rosa</name>
<affiliation wicri:level="1">
<mods:affiliation>Istituto di Chimica del Riconoscimento Molecolare (CNR), c/o Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Rome, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto di Chimica del Riconoscimento Molecolare (CNR), c/o Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Rome</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Brancaccio, Andrea" sort="Brancaccio, Andrea" uniqKey="Brancaccio A" first="Andrea" last="Brancaccio">Andrea Brancaccio</name>
<affiliation wicri:level="1">
<mods:affiliation>Istituto di Chimica del Riconoscimento Molecolare (CNR), c/o Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Rome, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto di Chimica del Riconoscimento Molecolare (CNR), c/o Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Rome</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Blake, Derek J" sort="Blake, Derek J" uniqKey="Blake D" first="Derek J." last="Blake">Derek J. Blake</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Heath Park, Cardiff, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Heath Park, Cardiff</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>E-mail: blakedj@cardiff.ac.uk</mods:affiliation>
<country wicri:rule="url">Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Correspondence address: Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Henry Wellcome Building for Biomedical Research in Wales, Heath Park, Cardiff, CF14 4XN, UK.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country>
<wicri:regionArea>Correspondence address: Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Henry Wellcome Building for Biomedical Research in Wales, Heath Park, Cardiff, CF14 4XN</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C7EE1610CBF1DC4111B52196C746F0085EC33EEC</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/humu.21561</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-CTT9SWRN-3/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001237</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001237</idno>
<idno type="wicri:Area/Istex/Curation">001237</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">A gain‐of‐glycosylation mutation associated with myoclonus‐dystonia syndrome affects trafficking and processing of mouse ε‐sarcoglycan in the late secretory pathway</title>
<author>
<name sortKey="Waite, Adrian" sort="Waite, Adrian" uniqKey="Waite A" first="Adrian" last="Waite">Adrian Waite</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Heath Park, Cardiff, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Heath Park, Cardiff</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Pharmacology, University of Oxford, Oxford, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacology, University of Oxford, Oxford</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="De Rosa, Maria Cristina" sort="De Rosa, Maria Cristina" uniqKey="De Rosa M" first="Maria Cristina" last="De Rosa">Maria Cristina De Rosa</name>
<affiliation wicri:level="1">
<mods:affiliation>Istituto di Chimica del Riconoscimento Molecolare (CNR), c/o Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Rome, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto di Chimica del Riconoscimento Molecolare (CNR), c/o Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Rome</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Brancaccio, Andrea" sort="Brancaccio, Andrea" uniqKey="Brancaccio A" first="Andrea" last="Brancaccio">Andrea Brancaccio</name>
<affiliation wicri:level="1">
<mods:affiliation>Istituto di Chimica del Riconoscimento Molecolare (CNR), c/o Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Rome, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto di Chimica del Riconoscimento Molecolare (CNR), c/o Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Rome</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Blake, Derek J" sort="Blake, Derek J" uniqKey="Blake D" first="Derek J." last="Blake">Derek J. Blake</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Heath Park, Cardiff, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Heath Park, Cardiff</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>E-mail: blakedj@cardiff.ac.uk</mods:affiliation>
<country wicri:rule="url">Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Correspondence address: Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Henry Wellcome Building for Biomedical Research in Wales, Heath Park, Cardiff, CF14 4XN, UK.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country>
<wicri:regionArea>Correspondence address: Department of Psychological Medicine and Neurology, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Henry Wellcome Building for Biomedical Research in Wales, Heath Park, Cardiff, CF14 4XN</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Human Mutation</title>
<title level="j" type="alt">HUMAN MUTATION</title>
<idno type="ISSN">1059-7794</idno>
<idno type="eISSN">1098-1004</idno>
<imprint>
<biblScope unit="vol">32</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1246">1246</biblScope>
<biblScope unit="page" to="1258">1258</biblScope>
<biblScope unit="page-count">13</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-11">2011-11</date>
</imprint>
<idno type="ISSN">1059-7794</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1059-7794</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Amino</term>
<term>Asparagine</term>
<term>Biol</term>
<term>Biotinylated</term>
<term>Biotinylation</term>
<term>Carvalho aguiar</term>
<term>Cell surface</term>
<term>Chloroquine</term>
<term>Control experiments</term>
<term>Degradation</term>
<term>Deletion</term>
<term>Dystonia</term>
<term>Dystroglycan</term>
<term>Ectodomain</term>
<term>Ectopic</term>
<term>Ectopic glycan</term>
<term>Endo</term>
<term>Erad</term>
<term>Esapa</term>
<term>Extracellular</term>
<term>Extracellular region</term>
<term>Genet</term>
<term>Glycan</term>
<term>Glycosylation</term>
<term>Human mutation</term>
<term>Immunoprecipitated</term>
<term>Intracellular</term>
<term>Klein</term>
<term>Late secretory pathway</term>
<term>Leupeptin</term>
<term>Lysosomal</term>
<term>Lysosomal degradation</term>
<term>Lysosome</term>
<term>Missense</term>
<term>Missense mutations</term>
<term>Murine</term>
<term>Muscular dystrophy</term>
<term>Mutant</term>
<term>Mutant protein</term>
<term>Mutation</term>
<term>Neurology</term>
<term>Ozelius</term>
<term>Pathway</term>
<term>Plasma membrane</term>
<term>Pngase</term>
<term>Protein levels</term>
<term>Proteolytic</term>
<term>Proteolytic processing</term>
<term>Quality control</term>
<term>Receptor</term>
<term>Sarcoglycan</term>
<term>Secretory</term>
<term>Secretory pathway</term>
<term>Sgce</term>
<term>Supp</term>
<term>Transfected</term>
<term>Transfected cells</term>
<term>Untreated</term>
<term>Vogt</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Missense mutations in the SGCE gene encoding ε‐sarcoglycan account for approximately 15% of SGCE‐positive cases of myoclonus‐dystonia syndrome (MDS) in humans. In this study, we show that while the majority of MDS‐associated missense mutants modeled with a murine ε‐sarcoglycan cDNA are substrates for endoplasmic reticulum‐associated degradation, one mutant, M68T (analogous to human c.275T>C, p.M92T), located in the Ig‐like domain of ε‐sarcoglycan, results in a gain‐of‐glycosylation mutation producing a protein that is targeted to the plasma membrane, albeit at reduced levels compared to wild‐type ε‐sarcoglycan. Removal of the ectopic N‐linked glycan failed to restore efficient plasma membrane targeting of M68T demonstrating that the substitution rather than the glycan was responsible for the trafficking defect of this mutant. M68T also colocalized with CD63‐positive vesicles in the endosomal–lysosomal system and was found to be more susceptible to lysosomal proteolysis than wild‐type ε‐sarcoglycan. Finally, we demonstrate impaired ectodomain shedding of M68T, a process that occurs physiologically for ε‐sarcoglycan resulting in the lysosomal trafficking of the intracellular C‐terminal domain of the protein. Our findings show that functional analysis of rare missense mutations can provide a mechanistic insight into the pathogenesis of MDS and the physiological role of ε‐sarcoglycan. Hum Mutat 32:1246–1258, 2011. ©2011 Wiley Periodicals, Inc.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001237 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001237 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:C7EE1610CBF1DC4111B52196C746F0085EC33EEC
   |texte=   A gain‐of‐glycosylation mutation associated with myoclonus‐dystonia syndrome affects trafficking and processing of mouse ε‐sarcoglycan in the late secretory pathway
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021